313 related articles for article (PubMed ID: 25787230)
1. Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study - .
Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Toyama Y; Yamada T; Doi M; Morita H; Ito H;
Circ J; 2015; 79(6):1315-22. PubMed ID: 25787230
[TBL] [Abstract][Full Text] [Related]
2. An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study.
Miyoshi A; Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Okawa K; Kawamoto K; Morita H; Ito H
J Cardiol; 2017 Nov; 70(5):425-431. PubMed ID: 28673507
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.
Conraads VM; Tavazzi L; Santini M; Oliva F; Gerritse B; Yu CM; Cowie MR
Eur Heart J; 2011 Sep; 32(18):2266-73. PubMed ID: 21362703
[TBL] [Abstract][Full Text] [Related]
4. Lifestyle Modification or Medication to Improve Condition of Patients With Asymptomatic Heart Failure - Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization II (MOMOTARO II) Study.
Miyoshi A; Nishii N; Okamoto Y; Fujita S; Kawamoto K; Okawa K; Hiramatsu S; Nakamura K; Morita H; Ito H
Circ J; 2020 Feb; 84(3):456-462. PubMed ID: 32037380
[TBL] [Abstract][Full Text] [Related]
5. Intrathoracic impedance monitoring to predict decompensated heart failure.
Ypenburg C; Bax JJ; van der Wall EE; Schalij MJ; van Erven L
Am J Cardiol; 2007 Feb; 99(4):554-7. PubMed ID: 17293202
[TBL] [Abstract][Full Text] [Related]
6. Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients.
Vamos M; Nyolczas N; Bari Z; Bogyi P; Muk B; Szabo B; Ancsin B; Kiss RG; Duray GZ
Cardiol J; 2018; 25(2):236-244. PubMed ID: 28653309
[TBL] [Abstract][Full Text] [Related]
7. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).
Domenichini G; Rahneva T; Diab IG; Dhillon OS; Campbell NG; Finlay MC; Baker V; Hunter RJ; Earley MJ; Schilling RJ
Europace; 2016 Mar; 18(3):428-35. PubMed ID: 26683599
[TBL] [Abstract][Full Text] [Related]
8. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: the CONNECT-OptiVol study.
Zabel M; Vollmann D; Lüthje L; Seegers J; Sohns C; Zenker D; Hasenfuss G
Contemp Clin Trials; 2013 Jan; 34(1):109-16. PubMed ID: 23073567
[TBL] [Abstract][Full Text] [Related]
9. Integration of automatic intrathoracic fluid content measurement into clinical decision making in patients with congestive heart failure.
Knackstedt C; Mischke K; Schimpf T; Waringer J; Fache K; Frechen D; Gramley F; Kelm M; Schauerte P
Pacing Clin Electrophysiol; 2008 Aug; 31(8):961-7. PubMed ID: 18684251
[TBL] [Abstract][Full Text] [Related]
10. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure.
Vollmann D; Nägele H; Schauerte P; Wiegand U; Butter C; Zanotto G; Quesada A; Guthmann A; Hill MR; Lamp B;
Eur Heart J; 2007 Aug; 28(15):1835-40. PubMed ID: 17309902
[TBL] [Abstract][Full Text] [Related]
12. New Index Obtained From Intrathoracic Impedance Measurements - Could MOMOTARO Find the Key to Heart Failure Management in the Modern Treasure Chest? - .
Seo Y; Aonuma K
Circ J; 2015; 79(6):1209-10. PubMed ID: 25912806
[No Abstract] [Full Text] [Related]
13. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
[TBL] [Abstract][Full Text] [Related]
14. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system.
Forleo GB; Panattoni G; Schirripa V; Papavasileiou LP; Della Rocca DG; Politano A; Ticconi F; Biscione C; Sergi D; Di Molfetta A; Santini L; Capria A; Romeo F
J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):726-32. PubMed ID: 23996011
[TBL] [Abstract][Full Text] [Related]
15. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: relationship to changes in NT-proBNP.
Lüthje L; Vollmann D; Drescher T; Schott P; Zenker D; Hasenfuss G; Unterberg C
Eur J Heart Fail; 2007; 9(6-7):716-22. PubMed ID: 17462948
[TBL] [Abstract][Full Text] [Related]
16. Fundamentals of intrathoracic impedance monitoring in heart failure.
Wang L
Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of CorVue intrathoracic impedance alert with device-measured physical activity in predicting heart failure events.
Wakabayashi Y; Kobayashi M; Ichikawa T; Koyama T; Abe H
Heart Vessels; 2021 Aug; 36(8):1166-1174. PubMed ID: 33725163
[TBL] [Abstract][Full Text] [Related]
18. Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.
Zile MR; Sharma V; Johnson JW; Warman EN; Baicu CF; Bennett TD
Circ Heart Fail; 2016 Jan; 9(1):e002543. PubMed ID: 26699393
[TBL] [Abstract][Full Text] [Related]
19. Analysis of different device-based intrathoracic impedance vectors for detection of heart failure events (from the Detect Fluid Early from Intrathoracic Impedance Monitoring study).
Heist EK; Herre JM; Binkley PF; Van Bakel AB; Porterfield JG; Porterfield LM; Qu F; Turkel M; Pavri BB;
Am J Cardiol; 2014 Oct; 114(8):1249-56. PubMed ID: 25150135
[TBL] [Abstract][Full Text] [Related]
20. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert.
Small RS; Wickemeyer W; Germany R; Hoppe B; Andrulli J; Brady PA; Labeau M; Koehler J; Sarkar S; Hettrick DA; Tang WH
J Card Fail; 2009 Aug; 15(6):475-81. PubMed ID: 19643357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
